B3GNT2 and cancer: The effects of MCL1 and B3GNT2 overexpression could be generalized to six and seven of the additional cell lines respectively, demonstrating the broad applicability of these candidate genes to other cancer types and supporting the patient tumor analyses (Supplementary Fig. 3a, b).